Blog
Stay up-to-date on news and events in the transplantation community
Categories:
Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOT): A randomized, open-label, clinical trial
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. Panayotova et al. published...
Brief Bubble and Intermittent Surface Oxygenation Is a Simple and Effective Alternative for Membrane Oxygenation During Hypothermic Machine Perfusion in Kidneys
A study by Darius et al. sought to evaluate the use of direct bubble and intermittent surface oxygenation during continuous HMP as an alternative to using a membrane oxygenator. They evaluated the renal flow, resistance and concentration of pO2 in the perfusate as...
Intermittent Surface Oxygenation Results in Similar Mitochondrial Protection and Maintenance of Aerobic Metabolism as Compared to Continuous Oxygenation during Kidney HMP
A study by Darius et al. evaluated the metabolic effect of a short interruption of surface oxygenation compared to continuous surface and membrane oxygenation in a pig kidney model. They looked at ATP levels as well as the pO2 measures, renal flow and resistance, and...
First clinical kidney transplantation series using brief bubble and direct surface oxygenation as alternative for membrane oxygenation during HMP
A study by Darius et al. reported on the first 5 cases of using the method of bubble and intermittent surface oxygenation during HMP in human renal transplantation. This case study provided information on 3 DCD donors of which 5 of the 6 kidneys were allocated to...
LifePort Liver Transporter by Organ Recovery Systems Achieves 100 Perfused Livers in Continued Access Study
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. Organ Recovery Systems (ORS)...
Decreased incidence of DGF in a high-DGF population
A recent paper published in Brazil by Tedesco-Silva et al. sought to determine the impact of hypothermic machine perfusion (HMP) on kidneys with a high incidence of delayed graft function (DGF). They performed a paired kidney analysis of 80 kidney pairs and evaluated...
LifePort Liver Transporter by Organ Recovery Systems Wins Fast Company’s 2023 Innovation by Design Award in the ‘Health’ Category
Organ Recovery Systems (ORS) is honored to announce that its LifePort Liver Transporter was selected as the winner in the ‘Health’ category in Fast Company’s Innovation by Design Awards for 2023. The Innovation by Design Awards, which can be found in the September...
The first use of hypothermic machine perfusion in Korea to recover a procured kidney graft and prevent prolonged cold ischemic time: a case report
Shin et al. reported on the first deceased donor kidney transplant case using hypothermic machine perfusion (HMP) on Jeju Island, Korea. A single deceased donor with several hours of marginal oxygen saturation had both kidneys assigned to Jeju Island. Due to...
Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In a pre-clinical study...
David’s Transplant Journey
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. In this powerful video, we...
Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era
A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...
Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?
In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...
Business Wire—Organ Recovery Systems’ LifePort Liver Transporter Preserves First Livers for Transplant as Part of the PILOT Continued Access Study
LifePort Liver Transporter has not been cleared or approved by FDA, and the safety and effectiveness of the LifePort Liver Transporter has not been established. LifePort Liver Transporter is not available for sale within the United States. We are proud to announce...
Business Wire—LifePort Kidney Transporter Awarded Exclusive Contract for Kidney Transplant Preservation Services in Belgium
We are proud to announce that the first kidney has officially been pumped using the LifePort Kidney Transporter in Belgium under a newly signed contract that names Organ Recovery Systems as the exclusive provider of kidney preservation services at seven transplant...
Machine Perfusion in Liver Transplantation: A Systematic Review and Meta-Analysis
A systematic review and meta-analysis by Jakubauskas et al. aimed to review the literature reporting liver transplant outcomes when using normothermic machine perfusion (NMP) or hypothermic machine perfusion (HMP) for organ preservation compared to static cold storage...
MedTech Insight—Organ Transplant Surgery Has Advanced – Organ Storage Should Too
In this article, MedTech Insight highlights machine preservation of donor organs with LifePort technology. By increasing utilization of donor organs and transporting them longer distances, LifePort systems may aid clinicians to make access to transplant more equitable...
Saint-Luc—World first: new technique for preserving kidney grafts
We are proud to announce that Cliniques universitaires Saint-Luc transplanted the first kidney perfused in the LifePort Kidney Transporter after introducing supplemental oxygen! The link showcases an interview in French with kidney transplant surgeon Professor Tom...
Hypothermic Machine Perfusion as a National Standard Preservation Method for Deceased Donor Kidneys
An article published in Transplantation by Brat et al. presented the evaluation of a 2-year project to implement continuous nonoxygenated hypothermic machine perfusion (HMP) as standard of care for all types of deceased donor kidneys in the Netherlands. The...